<DOC>
	<DOCNO>NCT02886494</DOCNO>
	<brief_summary>A Randomized , Double-Blind , Vehicle-Controlled , Parallel , Phase II Study Evaluate Efficacy Safety BAC Patient Alzheimer 's Disease Vascular Dementia</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety BAC Patient With Alzheimer 's Disease Vascular Dementia</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Dementia , Vascular</mesh_term>
	<criteria>1 . With either gender age least 40 year old 2 . With diagnosis one follow disease i. Vascular dementia accord NINDSAIREN International Workshop criterion ii . Alzheimer 's disease accord NIAAA criterion iii . `` Mixed '' dementia ( possible Alzheimer 's disease cerebrovascular disease ) accord NIAAA criterion Note : 1 . NINDSAIREN : National Institute Neurological Disorders Stroke Association Internationale pour la Recherche et l'Enseignement en Neurosciences 2 . NIAAA : National Institute AgingAlzheimer 's Association 3 . With mildtomoderate dementia ( score MiniMental State Examination ( MMSE ) define 10 24 score ADASCog least 12 ) 4 . Able read , write , communicate , understand cognitive testing instruction 5 . Having responsible caregiver spend least 4 hour daily patient . The caregiver accompany patient study visit , , supervise administration study drug , able ass patient 's condition 6 . Patients responsible caregiver willing able provide write informed consent form 1 . With large vessel thrombosis ( thrombotic stroke occur large artery ) 2 . With radiological evidence brain disorder ( subdural hematoma , posttraumatic / postsurgery ) 3 . With dementia cause brain disease except Alzheimer 's disease vascular dementia ( e.g . Parkinson 's disease , demyelinate disease central nervous system , tumor , hydrocephalus , head injury , central nervous system infection include syphilis , acquire immune deficiency syndrome , etc . ) 4 . With clinical evidence pulmonary , hepatic , gastrointestinal , metabolic , endocrine life threaten disease judge investigator suitable enter study 5 . With clinically unstable hypertension , diabetes mellitus , cardiac disease last 3 month 6 . Ever hospitalize stroke acute coronary syndrome previous 3 month prior screen 7 . Drug alcohol abuse within previous 12 month screen . 8 . With one follow abnormal laboratory parameter : hemoglobin &lt; 10 mg/dL platelet &lt; 100*109/L ; creatinine total bilirubin 1.5 time upper limit value ; alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) , alkaline phosphate ( ALP ) , γglutamyl transferase ( γGT ) 2 time upper limit normal , thyroidstimulating hormone ( TSH ) 2.5 time upper limit value less low limit value normal 9 . With severe depression grade Diagnostic Statistical Manual Mental Disorders , Fifth Edition ( DSM5 ) Cornell Scale Depression Dementia ( CSDD ) 10 . With uncontrolled illness ( include , limited , follow : ongoing active infection include hepatitis B , C , HIV , active bleeding , symptomatic congestive heart failure , uncontrolled hypertension , unstable angina pectoris , cardiac arrhythmia ) judge investigator enter trial may detrimental patient 11 . With know suspected hypersensitivity ingredient study product vehicle 12 . Pregnant lactate premenopausal childbearing potential take reliable contraceptive method ( ) study period Note : Reliable contraceptive method consider : 1 . Established use oral , injected implant hormonal method contraception &gt; 3 month prior baseline . 2 . Placement intrauterine device ( IUD ) intrauterine system ( IUS ) &gt; 3 month prior baseline . 3 . Barrier method contraception : Condom Occlusive cap ( diaphragm cervical/vault cap ) spermicidal foam/gel/film/cream/suppository 4 . Partner male sterilization ( i.e. , vasectomy ) &gt; 1 month screen 13 . Enrollment investigational drug trial within 4 week screen visit 14 . Experienced dosage increment routinely use drug list follow within past three month Screening visit 1. medications/treatments Alzheimer 's disease vascular dementia 2. antipsychotic medication include limited selective serotonin reuptake inhibitor ( SSRIs ) , benzodiazepine ( BZD ) 3 . Vitamin B12 4. drug thyroid disease 15 . Current antiplatelet drug ( antiaggregant ) except dosage include limited aspirin &lt; = 100mg/day , clopidogrel &lt; = 75mg/day , ticagrelor &lt; = 180mg/day , dipyridamole &lt; = 400mg/day 16 . Caregivers psychotic symptom , imminently suicidal , unstable medical condition ( e.g . recent heart attack , recent stroke , episodes dizziness , faint attack ) significant orthopaedic problem .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>